Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07402226 · ClinicalTrials.gov registry record · NA
Systemic Sclerosis DIet for GastrointESTinal Symptoms
A NA study, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07402226: Recruiting NA study, sponsored by University of Michigan.
NCT07402226 is a NA study that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07402226, a NA study, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This research will evaluate the effect of diets on bloating/distention, assess changes in abdominal pain, and overall gastrointestinal symptom burden in Systemic Sclerosis. The researchers will do this by comparing outcomes of people assigned to 3 different diets. Following the research specifics of the diets will be available upon contact with the details listed below.
Primary Outcome
As assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Scale v1.1 - Gastrointestinal Gas and Bloating 13a - 13 questions with raw summed scores ranging from 13-36.
Interventions
- BEHAVIORAL Diet 1: Restriction of fermentable carbohydrates
- BEHAVIORAL Diet 2: Elimination of foods harmful to gut barrier and microbiome
- BEHAVIORAL Diet 3: Regular meal patterns, soluble fiber, and portion control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-03-16 |
| Est. Completion | 2027-04 |
| Phase | NA |
What NCT07402226 shows while recruiting
NCT07402226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Diet 1: Restriction of fermentable carbohydrates is the first listed.
NCT07402226 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07402226 about?
NCT07402226 is a clinical study titled "Systemic Sclerosis DIet for GastrointESTinal Symptoms". This research will evaluate the effect of diets on bloating/distention, assess changes in abdominal pain, and overall gastrointestinal symptom burden in Systemic Sclerosis. The researchers will do this by comparing outcomes of people assigned to 3 different diets. Following the research specifics of...
What is the current status of trial NCT07402226?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-03-16. Estimated completion is 2027-04.
What interventions are being tested in trial NCT07402226?
The interventions under investigation include: Diet 1: Restriction of fermentable carbohydrates (BEHAVIORAL), Diet 2: Elimination of foods harmful to gut barrier and microbiome (BEHAVIORAL), Diet 3: Regular meal patterns, soluble fiber, and portion control (BEHAVIORAL).
Who is sponsoring clinical trial NCT07402226?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07402226's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI